Nuwellis (NUWE) Return on Capital Employed (2012 - 2026)
Nuwellis' (NUWE) quarterly Return on Capital Employed came in at 448.98% in Q1 2026, down 28543.0% YoY from N/an in Q1 2025, and down 62.47% on a QoQ basis from 276.34% in Q4 2025.
Nuwellis (NUWE) Return on Capital Employed (2012 - 2026) Analysis & Trends
Nuwellis (NUWE) has 15 years of Return on Capital Employed data on file, last reported at 448.98% in Q1 2026.
- Quarterly Return on Capital Employed fell 28543.0% year-over-year to 448.98% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 448.98% (down 28543.0% YoY) and the FY2025 annual result came in at 223.96%, down 7256.0% from the prior year.
- Return on Capital Employed slipped to 448.98% in Q1 2026, from 276.34% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 75.29% in Q1 2022 to a low of 573.81% in Q2 2024.
- A 5-year average of 228.9% and a median of 191.53% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed tumbled 42730 bps — and 2025, when it surged 33907 bps.
- Tracing NUWE's Return on Capital Employed over 5 years: stood at 101.8% in 2022, then plunged by 133 bps to 237.31% in 2023, then grew by 19 bps to 191.53% in 2024, then plunged by 44 bps to 276.34% in 2025, then tumbled by 62 bps to 448.98% in 2026.
- The last three Return on Capital Employed figures came in at 448.98% (Q1 2026), 276.34% (Q4 2025), and 217.95% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Nuwellis | 203,898.38 | -3.72 Mn | 1.50 Mn | -319.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -319.09% |
| Mar 31, 2026 | -448.98% |
| Dec 31, 2025 | -276.34% |
| Sep 30, 2025 | -217.95% |
| Jun 30, 2025 | -234.74% |
| Mar 31, 2025 | -163.54% |
| Dec 31, 2024 | -191.53% |
| Sep 30, 2024 | -324.52% |
| Jun 30, 2024 | -573.81% |
| Mar 31, 2024 | -424.56% |
| Dec 31, 2023 | -237.31% |
| Sep 30, 2023 | -176.86% |
| Jun 30, 2023 | -146.52% |
| Mar 31, 2023 | -106.51% |
| Dec 31, 2022 | -101.80% |
| Sep 30, 2022 | -102.18% |
| Jun 30, 2022 | -88.86% |
| Mar 31, 2022 | -75.29% |
| Dec 31, 2021 | -67.45% |
| Sep 30, 2021 | -69.39% |